Navigation Links
Novavax Announces Release Date of 2007 Fourth Quarter, Full Year Financial Results and Investor Conference Call
Date:3/7/2008

ROCKVILLE, Md., March 7 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will report its 2007 fourth quarter and full-year financial results in a press release to be issued after 8:00 a.m. Eastern Time on Friday, March 14, 2008. The Company will hold an investor conference call to discuss its financial results at 10:00 a.m. Eastern Time on Friday, March 14. The call will be hosted by Novavax President and Chief Executive Officer Dr. Rahul Singhvi and other members of senior management. A question and answer session will follow the financial results overview. The dial-in number for the conference call is 1 (866) 244 4629 (International: (703) 639 1176).

A live audio webcast of the conference call will be available at http://www.novavax.com under Investors/Events. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. A replay of the webcast will be available on the website for 90 days after the call and a replay of the conference call will also be available by telephone beginning March 14 at noon through March 21. To access the replay, dial 1 (888) 266 2081 and enter pass code 1202787.

About Novavax, Inc.

Novavax Inc. is a clinical stage vaccine company committed to leading the global fight against infectious disease by creating novel, highly potent vaccines that are safer and more effective than current preventive options. Using the company's proprietary virus-like particle (VLP) and Novasome(R) adjuvant technologies, Novavax is developing vaccines to protect against H5N1 pandemic influenza, seasonal flu and other viral diseases. Novavax's particulate vaccines closely match disease-causing viruses while lacking the genetic material to cause disease, which provides potential for greater immune protection at lower doses than current vaccines. With an exclusive portable manufacturing system that allows for rapid mass-production of vaccines, Novavax is uniquely positioned to meet global public health needs. Additional information about Novavax is available at http://www.novavax.com and in the company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Novavax CEO to Present at the Partnering for Global Health Forum
2. Novavax CEO to Present at Susquehannas Second SIGnificant Options in Healthcare Conference
3. Novavax Announces Release Date of 2007 Third Quarter Financial Results and Investor Conference Call
4. Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb
5. Novavax CEO to Present at the 2007 UBS Global Life Sciences Conference
6. Genoptix Announces Participation at Lehman Brothers 11th Annual Global Health Care Conference
7. Susan G. Komen for the Cure(R) Announces Global Promise Fund to Help Women Worldwide
8. ACS Announces $57 Million Contract With Missouri HealthNet
9. Nfocus Neuromedical Announces Acquisition of StarFire Medical
10. QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Cancer Indexes
11. Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... STAMFORD, CONNECTICUT (PRWEB) , ... April 29, 2016 , ... ... 5K Run/Walk” at Cove Island Park on Sunday, with sunny skies, a light breeze ... event, raising nearly $33,000. , The 5k Run and Walk and 1-mile ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... announced that student team BioCellection won the $30,000 Perlman Grand Prize of the 2016 ... the Gloeckner Undergraduate Award, the Michelson People’s Choice Award, and the Committee Award ...
(Date:4/29/2016)... ... ... is the deadliest type of skin cancer. Although only about 1 percent of skin cancer ... than 10,000 people are expected to die of melanoma this year. The risk increases with ... the most commonly diagnosed cancers in young women. A recent breakthrough in genetic studies may ...
(Date:4/29/2016)... ... , ... For those who skip meals occasionally (which is pretty much everyone), ... many new lifestyle diet tips offered by nutritionists Pam Bonney and Priya Lawrence of ... show. Bonny and Lawrence noted that because proper nutrition, including water, provides energy during ...
(Date:4/29/2016)... N.J. (PRWEB) , ... April 29, 2016 , ... ... digital and print media enterprise focused entirely on patients with cancer, today announced ... California, was chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... N.J. , April 28, 2016   Acsis ... today announced that leading IT market research and advisory ... " in the IDC MarketScape: Worldwide Pharmaceutical Track and ... 2016).  The report provides an assessment of the capabilities ... track and trace software market. Logo - ...
(Date:4/28/2016)... PUNE, India , April 28, 2016 /PRNewswire/ ... - Pipeline Review, H1 2016" is a report ... pipeline and helps strengthen R&D pipelines by identifying ... best-in-class products. Company Profiles discussed in ... Menarini Industrie Farmaceutiche Riunite Srl, AbbVie Inc., Abiogen ...
Breaking Medicine Technology: